Views & Analysis Calls to end the silent epidemic of PTHP Campaigners want to raise awareness of post-traumatic hypopituitarism following a head injury.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
News NICE approval for Keytruda a 'milestone' in lung cancer But drug will not be funded for longer than two years.
News Pfizer fears rough ride with NICE over breast cancer drug Concerns over NICE's treatment of add-on therapies.
News Janssen’s Imbruvica latest to gain NICE approval after price... Leukaemia drug latest cancer treatment to gain NICE approval
Views & Analysis Three NICE thresholds for cost-effectiveness: does that make... NICE wants a new, third threshold for rare disease drugs - but what's the evidence behind it?
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
